These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 28477098)

  • 1. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
    Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
    Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
    Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
    Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from WATCHMAN generation-2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: Incidence and predictors of device-related thrombosis and short- to mid-term outcomes.
    Chatani R; Kubo S; Tasaka H; Nishiura N; Mushiake K; Ono S; Maruo T; Kadota K
    Catheter Cardiovasc Interv; 2024 Aug; 104(2):318-329. PubMed ID: 38895767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and Secondary Stroke Prevention Using Left Atrial Appendage Closure with Watchman Devices in Atrial Fibrillation Patients: A Single Center Experience from Mainland China.
    Chen Y; Zhang Y; Huang W; Huang K; Xu B; Su XI
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):607-614. PubMed ID: 28084014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.
    Saw J; Fahmy P; DeJong P; Lempereur M; Spencer R; Tsang M; Gin K; Jue J; Mayo J; McLaughlin P; Nicolaou S
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1198-206. PubMed ID: 25851318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.